Showing results (181-190 of 250) with videos related to
Sort By:
Pageof 25
Cancer|April 21, 2012
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or olderJacob G Scott, Luc Bauchet, Tyler J Fraum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2018
BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET StudyThomas Kaley, Mehdi Touat, Vivek Subbiah, et al.Journal of Neuro-Oncology|January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomasLakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.Annals of Neurology|May 24, 2021
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective StudyBabak B Navi, Carla P Sherman, Richard Genova, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal FluidElena I Pentsova, Ronak H Shah, Jiabin Tang, et al.Cancer Discovery|June 9, 2018
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic LeukemiaBianca D Santomasso, Jae H Park, Darin Salloum, et al.Journal of the Endocrine Society|September 1, 2021
Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary CarcinomaAndrew L Lin, Viviane Tabar, Robert J Young, et al.Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.Journal of Neuro-Oncology|June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomaAndrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.Journal of Neuro-Oncology|December 23, 2003
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendrogliomaLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.Pageof 25